Hemoglobin glutamer-250 (bovine, HbO2 Therapeutics) | Interleukin Related interleukin-related.com

Product Name :
Hemoglobin glutamer-250 (bovine, HbO2 Therapeutics)

Search keywords :
AA10

drugId :
null

Target Vo:
Hemoglobins

Target Vo Short Name :
Hemoglobins

Moa_Name:
Oxygen carriers

First Approval Country :
South Africa

First Approval Date Filter:
2010

Origin Company_Name :
Biopure Corporation

Active Company_Name :

Active Indication_Name:
Anemia

In Active Indication_Name:
Angina, Unstable

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Erk1 (pT202/pY204)+Erk2 (pT185/pY187) Antibody (YA455)
Phospho-Histone H2A.X (Ser139) Antibody (YA191)
eIF4B Antibody: eIF4B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to eIF4B. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts